🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Comparison of Motor Relearning Program and Electric Muscle Stimulation in Subacute Stroke Patients

RecruitingNAAges 40 Years - 65 YearsAllMontiha Azeem
NCT07720622 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Stroke is one of the leading causes of long-term disability worldwide, with upper limb motor impairment being a common consequence that limits independence in activities of daily living. The Motor Relearning Program (MRP) is a task-oriented rehabilitation approach designed to improve motor recovery through repetitive functional practice. Electrical Muscle Stimulation (EMS) may further enhance muscle activation and facilitate motor recovery when combined with conventional rehabilitation. The purpose of this single-blinded randomized controlled trial is to compare the effectiveness of the Motor Relearning Program combined with Electrical Muscle Stimulation versus the Motor Relearning Program alone in improving upper limb function in individuals with subacute stroke. Thirty-six eligible participants with subacute stroke will be randomly allocated into two groups. Group A will receive MRP t

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 40-65 years * Both male and female * Sub acute stroke patients diagnosed by neurologist * Motor assessment scale score 2-3 * Subjects able to sit for 30 secs without using upper extremities for support. * Modified Ashworth scale value \< 2 Exclusion Criteria: * Patients with Mini Mental State Examination \<23 * Cognitive disorders and perceptual disorders * Any musculoskeletal disorders * Severe cardiac diseases
💊

What it tests

  • Motor Relearning Program
  • Electrical Muscle Stimulation
📍

Where

1 site
Shadman Medical Center, Lahore
Lahore, Pakistan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy